3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Phase 2
1
Phase 1/2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
5
Non-small Cell Lung Cancer Metastatic
1
Caucasian Patients With EGFR Mutation Positive Advanced NSCLC
1
Carcinoma
1
Interventions
lorlatinib
1
elemene
1
capmatinib
1
aumolertinib
1
aflutinib
1
Technetium Tc 99m Aggregated Albumin
1
Sunitinib
1
Sevoflurane
1
Radiotherapy
1
Propofol
1
Gefitinib
1
Fluorouracil
1
Craniotomy
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Carcinoma
×
Gefitinib
×
Clear all
NCT00608868
2012-09-28
SELINE
AstraZeneca
Phase 4
Completed
156 enrolled
14 charts